Tewksbury, MA – According to filings with the U.S. Securities and Exchange Commission, Corvia Medical is raising $13,115,114.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, George Fazio played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Corvia Medical

Corvia Medical, Inc., is dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices. The company has developed the world’s first transcatheter device designed to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF), ejection fraction, previously known as diastolic heart failure (DHF). The innovative InterAtrial Shunt Device (IASD) is designed to reduce elevated left atrial pressure (LAp), which is the main cause of heart failure symptoms.

To learn more about Corvia Medical, visit http://us.corviamedical.com/

Contact:
George Fazio, President and Chief Executive Officer
978-654-6123
https://www.linkedin.com/in/george-fazio-3231aa17/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved